Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07239219 · ClinicalTrials.gov registry record · NA
The Impact of Irrisept in Reducing Urinary Tract Infection During Urethral Catheter Removal.
A NA study of Urinary Tract Infection and Catheter Infection, sponsored by Ohio State University.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT07239219 is a NA study of Urinary Tract Infection and Catheter Infection that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 300 participants, below the 646-participant average among 11 other Urinary Tract Infection trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07239219, a NA study of Urinary Tract Infection and Catheter Infection, is actively recruiting participants, sponsored by Ohio State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
Given the high burden of post-catheter removal UTIs, this study aims to evaluate Irrisept instillation as a non-antibiotic intervention to reduce infection rates. By comparing Irrisept to saline irrigation, the study will provide critical insights into the efficacy of antiseptic bladder irrigation in preventing UTIs while minimizing antibiotic use. If successful, this approach could lead to new clinical guidelines for catheter removal protocols, improving patient outcomes and reducing healthcare costs.
Conditions Studied
Interventions
- OTHER 0.05% Chlorhexidine Gluconate
- OTHER Normal Saline
Study Locations (1)
Ohio
- The Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2025-12-31 |
| Est. Completion | 2028-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07239219
The ClinicalTrials.gov registry entry for NCT07239219 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 646-participant average among 11 other Urinary Tract Infection trials with a reported enrollment target (54% lower). The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Urinary Tract Infection appearing as the primary indexed condition, and to 2 interventions - of which 0.05% Chlorhexidine Gluconate is the first listed.
NCT07239219 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT07239219 about?
NCT07239219 is a clinical study titled "The Impact of Irrisept in Reducing Urinary Tract Infection During Urethral Catheter Removal.". Given the high burden of post-catheter removal UTIs, this study aims to evaluate Irrisept instillation as a non-antibiotic intervention to reduce infection rates. By comparing Irrisept to saline irrigation, the study will provide critical insights into the efficacy of antiseptic bladder irrigation i...
What is the current status of trial NCT07239219?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2025-12-31. Estimated completion is 2028-01-01.
What conditions does trial NCT07239219 study?
This clinical trial studies the following conditions: Urinary Tract Infection, Catheter Infection, Antibiotic.
What interventions are being tested in trial NCT07239219?
The interventions under investigation include: 0.05% Chlorhexidine Gluconate (OTHER), Normal Saline (OTHER).
Who is sponsoring clinical trial NCT07239219?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07239219 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Tract Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Chlorhexidine Antiseptic Irrigation of the Bowel Segment During Radical Cystectomy and Urinary Diversion
RECRUITING · NA
-
Cefpodoxime vs Ciprofloxacin for Acute Cystitis
COMPLETED · NA
-
Healthy.io Method Comparison & User Performance Study
COMPLETED · NA
-
ParentLink: Better and Safer Emergency Care for Children
COMPLETED
-
Trial to Evaluate the Efficacy and Safety of Cipro® XR in Treating Female Patients With Lower Urinary Tract Infections
COMPLETED · Phase 4
-
Skin Cleansing With Chlorhexidine to Decrease Hospital Acquired Infections
COMPLETED · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.